OUR PORTFOLIO

AIBODY

Medtech

AIBODY pioneers the frontier of digital physiology modelling. Boasting decades of cumulative expertise in healthcare, human physiology research and computational simulation, the UK tech company crafts exceptionally accurate digital representations of the human body's inner workings. What truly distinguishes AIBODY is its groundbreaking subcellular modelling technique — a proprietary approach that elevates their technology above their competition.

In contrast to competitors, AIBODY has a bottom-up approach to digital physiology. They model intricate biochemical and biomechanical transformations within individual cells. This allows for nuanced interventions, including adjustments at the levels of enzyme activity and ion channel functionality.

AIBODY’s mission is to lead the charge in delivering transformative, high-impact digital twinning solutions for the healthcare sector globally. A stellar showcase of their capabilities is Nova Heart — a cardiology-centric digital twin developed in a prestigious partnership with the German Heart Centre at Charité (DHZC).

aibody.io

AIBODY
IN THE PRESS

OUR NEWSROOM
ALL NEWS

OUR INVESTMENT
PORTFOLIO